FBFeng-Chen Bi

Feng-Chen Bi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Feng-Chen Bi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hui Yang

    Research Center of Medical Science and Technology, Ningxia Medical University, Yinchuan, China

    1 shared publication
  • Juan Li

    School of Pharmacy Ningxia Medical University Yinchuan People's Republic of China

    1 shared publication
  • Wen-Bin Deng

    School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Xiao-Li Guo

    School of Pharmacy, Ningxia Medical University, Yinchuan, China

    1 shared publication
  • Xiao-Yu Cheng

    Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital, Soochow University, Suzhou, China

    1 shared publication
  • Xin-He Yang

    School of Pharmacy, Ningxia Medical University, Yinchuan, China

    1 shared publication

Latest Publications

  • Open Access

    Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research

    by Feng-Chen Bi, Xin-He Yang, Xiao-Yu Cheng, Wen-Bin Deng, Xiao-Li Guo, Hui Yang, Yin Wang, Juan Li, Yao Yao

    Alzheimer’s disease (AD) is a neurodegenerative disease that currently cannot be cured by any drug or intervention, due to its complicated pathogenesis. Current animal and cellular models of AD are unable to meet research needs for AD. However, recent three-dimensional (3D) cerebral organoid models derived from human stem cells have provided a new tool to study molecular mechanisms and pharmaceutical developments of AD. In this review, we discuss the advantages and key limitations of the AD cerebral organoid system in comparison to the commonly used AD models, and propose possible solutions, in order to improve their application in AD research. Ethical concerns associated with human cerebral organoids are also discussed. We also summarize future directions of studies that will improve the cerebral organoid system to better model the pathological events observed in AD brains.